| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000011479 |
| Receipt No. | R000013427 |
| Official scientific title of the study | Effect of Tacrolimus on Dry Eye Syndrome Related to Chronic Graft-Versus-Host Disease. |
| Date of disclosure of the study information | 2013/08/24 |
| Last modified on | 2016/08/01 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Effect of Tacrolimus on Dry Eye Syndrome Related to Chronic Graft-Versus-Host Disease. | |
| Title of the study (Brief title) | Effect of tacrolimus on GVHD related dry eye. | |
| Region |
|
|
| Condition | ||
| Condition | Dry eye related to chronic GVHD | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the treatment efficacy of tacrolimus on chronic GVHD dry eye |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Anterior ocular segment remark
Corneal sensitivity Schirmer's test Tear film breakup time Fluorescein staining Rose-bengal staining Subjective symptom |
| Key secondary outcomes | Cytotechnology(IC, BC)
Biopsy Non-contact infrared meibography Laser confocal microscopy |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | YES |
| Institution consideration | |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Tacrolimus ophthalmic solution,
vitamin A ophthalmic solution, or/and sodium hyaluronate ophthalmic solution |
|
| Interventions/Control_2 | Artifical tears, vitamin A ophthalmic solution, or/and sodium hyaluronate ophthalmic solution | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1, Newly-diagnosed dry eye patients after hematopoietic stem cell transplantation
2, Dry eye patients according to the criteria of dry eye (2006 Japanese Dry Eye society) |
|||
| Key exclusion criteria | 1, Patients with Sjogren's syndrome, ocular pemphigoid, and Stevens-Johnson syndrome
2, Patients with a history of ophthalmic surgery 3, Patients wearing contact lens 4, Patients who will be applied radiation treatment during the study 5, Patients dosed cevimeline hydrochloride hydrate and /or pilocarpine(eye drop or oral drug) 6, Patients having a concern of becoming severe dry eye because of having GVHD in other organs and so on |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Yoko Ogawa |
| Organization | Keio University School of Medicine |
| Division name | Department of Ophthalmology |
| Address | Shinanomachi 35, Shinjuku-ku. Tokyo 160-8582 |
| TEL | 03-5363-3972 |
| Public contact | |
| Name of contact person | Yoko Ogawa |
| Organization | Keio University School of Medicine |
| Division name | Department of Ophthalmology |
| Address | Shinanomachi 35, Shinjuku-ku. Tokyo 160-8582 |
| TEL | 03-5363-3972 |
| Homepage URL | |
| yoko@z7.keio.jp | |
| Sponsor | |
| Institute | Keio University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grant-in Aid for Scientific Research |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | None |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 慶應義塾大学病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013427 |